Novo Nordisk AS (NONOF)
105.00
+2.16
(+2.10%)
USD |
OTCM |
Nov 22, 16:00
Novo Nordisk Price to Book Value: 25.84 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 25.84 |
| November 21, 2024 | 25.31 |
| November 20, 2024 | 25.97 |
| November 19, 2024 | 24.91 |
| November 18, 2024 | 24.91 |
| November 15, 2024 | 25.16 |
| November 14, 2024 | 26.04 |
| November 13, 2024 | 25.80 |
| November 12, 2024 | 25.95 |
| November 11, 2024 | 26.54 |
| November 08, 2024 | 27.25 |
| November 07, 2024 | 26.13 |
| November 06, 2024 | 27.26 |
| November 05, 2024 | 26.18 |
| November 04, 2024 | 27.07 |
| November 01, 2024 | 27.50 |
| October 31, 2024 | 26.87 |
| October 30, 2024 | 27.31 |
| October 29, 2024 | 27.30 |
| October 28, 2024 | 27.89 |
| October 25, 2024 | 28.40 |
| October 24, 2024 | 28.60 |
| October 23, 2024 | 28.16 |
| October 22, 2024 | 28.85 |
| October 21, 2024 | 29.37 |
| Date | Value |
|---|---|
| October 18, 2024 | 28.97 |
| October 17, 2024 | 28.52 |
| October 16, 2024 | 28.66 |
| October 15, 2024 | 30.13 |
| October 14, 2024 | 29.47 |
| October 11, 2024 | 29.91 |
| October 10, 2024 | 29.03 |
| October 09, 2024 | 28.48 |
| October 08, 2024 | 28.54 |
| October 07, 2024 | 29.09 |
| October 04, 2024 | 28.12 |
| October 03, 2024 | 28.12 |
| October 02, 2024 | 28.98 |
| October 01, 2024 | 29.16 |
| September 30, 2024 | 28.75 |
| September 27, 2024 | 32.73 |
| September 26, 2024 | 35.27 |
| September 25, 2024 | 34.45 |
| September 24, 2024 | 35.27 |
| September 23, 2024 | 34.31 |
| September 20, 2024 | 34.76 |
| September 19, 2024 | 36.69 |
| September 18, 2024 | 36.77 |
| September 17, 2024 | 36.31 |
| September 16, 2024 | 38.03 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
13.23
Minimum
Mar 23 2020
46.36
Maximum
Jun 25 2024
25.03
Average
23.90
Median
Price to Book Value Benchmarks
| Eli Lilly and Co | 49.87 |
| Genmab AS | 2.743 |
| Ascendis Pharma AS | -- |
| Galecto Inc | 0.3535 |
Price to Book Value Related Metrics
| PE Ratio | 34.02 |
| PS Ratio | 11.92 |
| PEG Ratio | 1.210 |
| Price to Free Cash Flow | 47.73 |
| Price | 105.00 |
| Earnings Yield | 2.94% |
| Market Cap | 466.54B |
| PEGY Ratio | 1.153 |
| Operating PE Ratio | 27.23 |
| Normalized PE Ratio | 34.02 |